| Dynamic balance of pro‐and anti‐inflammatory signals controls disease and limits pathology JM Cicchese, S Evans, C Hult, LR Joslyn, T Wessler, JA Millar, S Marino, ... Immunological reviews 285 (1), 147-167, 2018 | 382 | 2018 |
| Endothelial TGF-β signalling drives vascular inflammation and atherosclerosis PY Chen, L Qin, G Li, Z Wang, JE Dahlman, J Malagon-Lopez, S Gujja, ... Nature metabolism 1 (9), 912-926, 2019 | 345 | 2019 |
| Macrophage polarization drives granuloma outcome during Mycobacterium tuberculosis infection S Marino, NA Cilfone, JT Mattila, JJ Linderman, JAL Flynn, DE Kirschner Infection and immunity 83 (1), 324-338, 2015 | 241 | 2015 |
| M281, an anti‐FcRn antibody: pharmacodynamics, pharmacokinetics, and safety across the full range of IgG reduction in a first‐in‐human study LE Ling, JL Hillson, RG Tiessen, T Bosje, MP van Iersel, DJ Nix, ... Clinical Pharmacology & Therapeutics 105 (4), 1031-1039, 2019 | 176 | 2019 |
| Th17 cytokines differentiate obesity from obesity‐associated type 2 diabetes and promote TNF α production B Ip, NA Cilfone, AC Belkina, J DeFuria, M Jagannathan‐Bogdan, M Zhu, ... Obesity 24 (1), 102-112, 2016 | 152 | 2016 |
| Multi-scale modeling predicts a balance of tumor necrosis factor-α and interleukin-10 controls the granuloma environment during Mycobacterium tuberculosis infection NA Cilfone, CR Perry, DE Kirschner, JJ Linderman PloS one 8 (7), e68680, 2013 | 144 | 2013 |
| Enhancing retrosynthetic reaction prediction with deep learning using multiscale reaction classification JL Baylon, NA Cilfone, JR Gulcher, TW Chittenden Journal of chemical information and modeling 59 (2), 673-688, 2019 | 140 | 2019 |
| Strategies for efficient numerical implementation of hybrid multi-scale agent-based models to describe biological systems NA Cilfone, DE Kirschner, JJ Linderman Cellular and molecular bioengineering 8 (1), 119-136, 2015 | 127 | 2015 |
| Chronic mTOR activation induces a degradative smooth muscle cell phenotype G Li, M Wang, AW Caulk, NA Cilfone, S Gujja, L Qin, PY Chen, Z Chen, ... The Journal of clinical investigation 130 (3), 1233-1251, 2020 | 100 | 2020 |
| Computational modeling predicts IL-10 control of lesion sterilization by balancing early host immunity–mediated antimicrobial responses with caseation during Mycobacterium … NA Cilfone, CB Ford, S Marino, JT Mattila, HP Gideon, JAL Flynn, ... The Journal of Immunology 194 (2), 664-677, 2015 | 82 | 2015 |
| A computational tool integrating host immunity with antibiotic dynamics to study tuberculosis treatment E Pienaar, NA Cilfone, PL Lin, V Dartois, JT Mattila, JR Butler, JAL Flynn, ... Journal of theoretical biology 367, 166-179, 2015 | 81 | 2015 |
| Endothelial ERK1/2 signaling maintains integrity of the quiescent endothelium N Ricard, RP Scott, CJ Booth, H Velazquez, NA Cilfone, JL Baylon, ... Journal of Experimental Medicine 216 (8), 1874-1890, 2019 | 79 | 2019 |
| Quantitative systems pharmacology approaches applied to microphysiological systems (MPS): data interpretation and multi‐MPS integration J Yu, NA Cilfone, EM Large, U Sarkar, JS Wishnok, SR Tannenbaum, ... CPT: pharmacometrics & systems pharmacology 4 (10), 585-594, 2015 | 55 | 2015 |
| A multi-scale approach to designing therapeutics for tuberculosis JJ Linderman, NA Cilfone, E Pienaar, C Gong, DE Kirschner Integrative Biology 7 (5), 591-609, 2015 | 44 | 2015 |
| Quantum processor-inspired machine learning in the biomedical sciences RY Li, S Gujja, SR Bajaj, OE Gamel, N Cilfone, JR Gulcher, DA Lidar, ... Patterns 2 (6), 2021 | 41 | 2021 |
| Molecular profiling of rheumatoid arthritis patients reveals an association between innate and adaptive cell populations and response to anti-tumor necrosis factor V Farutin, T Prod’homme, K McConnell, N Washburn, P Halvey, CJ Etzel, ... Arthritis Research & Therapy 21 (1), 216, 2019 | 36 | 2019 |
| Systems pharmacology approach toward the design of inhaled formulations of rifampicin and isoniazid for treatment of tuberculosis NA Cilfone, E Pienaar, GM Thurber, DE Kirschner, JJ Linderman CPT: pharmacometrics & systems pharmacology 4 (3), 193-203, 2015 | 31 | 2015 |
| CPT: pharmacometrics Syst J Yu, NA Cilfone, EM Large, U Sarkar, JS Wishnok, SR Tannenbaum, ... Pharmacol 4 (585), 10.1002, 2015 | 31 | 2015 |
| An inflammatory T cell signature predicts obesity-associated type 2 diabetes (HUM3P. 262) B Ip, N Cilfone, M Zhu, R Kuchibhatla, M Azer, M McDonnell, C Apovian, ... The Journal of Immunology 194 (1_Supplement), 121.22-121.22, 2015 | 4 | 2015 |
| Statistical ai for advanced deep learning and probabilistic programing in the biosciences TW Chittenden, NA Cilfone, P Yang US Patent App. 16/851,949, 2020 | 3 | 2020 |
